Different haematological picture of congenital sideroblastic anaemia in a hemizygote and a heterozygote
Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpura
Current status of antifungal resistance and its impact on clinical practice
Effect of von Willebrand factor on inhibitor eradication in patients with severe haemophilia A: a systematic review
Guidelines for the diagnosis and treatment of cobalamin and folate disorders
Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study
Epidemiology of systemic mastocytosis in Denmark
PI3K-dependent multiple myeloma cell survival is mediated by the PIK3CA isoform
Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study
The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q)
Peripheral blood cells chimerism after unrelated cord blood transplantation in children: kinetics, predictive factors and impact on post-transplant outcome
Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation
Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin
Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopenia
Effects of oxidative stress on red blood cell rheology in sickle cell patients
Evaluation of the validity of Hb A2 and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in England
Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma
Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma – response to Meissner et al
Long-term survival after allogeneic stem cell transplantation for advanced stage multiple myeloma
Elevated incidence of chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients
The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors
Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma